Prime Capital Investment Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,004
| Closed | -$235K | – | 915 |
|
|
2024
Q1 | $235K | Buy |
4,004
+186
| +5% | +$10.9K | ﹤0.01% | 864 |
|
|
2023
Q4 | $229K | Buy |
+3,818
| New | +$229K | ﹤0.01% | 833 |
|
|
2023
Q3 | – | Sell |
-18,200
| Closed | -$1.66M | – | 755 |
|
|
2023
Q2 | $1.66M | Buy |
18,200
+14,800
| +435% | +$1.35M | 0.03% | 284 |
|
|
2023
Q1 | $224K | Buy |
+3,400
| New | +$224K | 0.01% | 486 |
|